Search

Brydon L Bennett

age ~53

from San Diego, CA

Also known as:
  • Brydon Bennett
  • Brydon Christina Bennett
  • Bennett Brydon
10835 Ashlar Pl, San Diego, CA 92131(858)5308057

Brydon Bennett Phones & Addresses

  • 10835 Ashlar Pl, San Diego, CA 92131 • (858)5308057
  • 4931 Diane Ave, San Diego, CA 92117 • (858)9741901
  • 5555 Oberlin Dr, San Diego, CA 92121
  • 7164 Schilling Ave, San Diego, CA 92126 • (858)5470714
  • Portage, MI

Us Patents

  • Methods For Treating Inflammatory Conditions Or Inhibiting Jnk

    view source
  • US Patent:
    7335676, Feb 26, 2008
  • Filed:
    Dec 16, 2003
  • Appl. No.:
    10/738640
  • Inventors:
    Brydon L. Bennett - San Diego CA, US
    Shripad S. Bhagwat - San Diego CA, US
    Anthony M. Manning - San Diego CA, US
    Brion W. Murray - San Diego CA, US
    Eoin C. O'Leary - San Diego CA, US
    Yoshitaka Satoh - San Diego CA, US
  • Assignee:
    Signal Pharmaceuticals, LLC - San Diego CA
  • International Classification:
    A61K 31/415
  • US Classification:
    514406
  • Abstract:
    This invention generally relates to methods for treating or preventing an inflammatory disease or disorder comprising administering to a patient in need thereof an effective amount of a Pyrazoloanthrone Derivative having the following structure:.
  • Methods Of Treatment And Prevention Using Haloaryl Substituted Aminopurines

    view source
  • US Patent:
    7759342, Jul 20, 2010
  • Filed:
    Feb 15, 2007
  • Appl. No.:
    11/708150
  • Inventors:
    Brydon L. Bennett - San Diego CA, US
    Kate Blease - San Diego CA, US
    Brian Edwin Cathers - San Diego CA, US
  • Assignee:
    Signal Pharmaceuticals, LLC - San Diego CA
  • International Classification:
    A61P 11/00
    C07D 473/32
    C07D 239/50
    C07D 239/48
    A61K 31/53
    A61P 3/10
  • US Classification:
    5142342, 5142634
  • Abstract:
    Provided herein are Aminopurine Compounds having the following structure:.
  • Methods Of Modulating Inflammatory Cell Recruitment And Gene Expression Using Haloaryl Substituted Aminopurines

    view source
  • US Patent:
    8440661, May 14, 2013
  • Filed:
    May 13, 2010
  • Appl. No.:
    12/779083
  • Inventors:
    Brydon L. Bennett - San Diego CA, US
    Kate Northcote - San Diego CA, US
    Brian Edwin Cathers - San Diego CA, US
  • Assignee:
    Signal Pharmaceuticals, LLC - San Diego CA
  • International Classification:
    A61P 11/00
    C07D 473/32
    C07D 239/50
    C07D 239/48
    A61K 31/53
    A61P 3/10
  • US Classification:
    5142342, 5142634
  • Abstract:
    Provided herein are Aminopurine Compounds having the following structure:.
  • Methods For Treating Inflammatory Conditions Or Inhibiting Jnk

    view source
  • US Patent:
    20040072888, Apr 15, 2004
  • Filed:
    Mar 24, 2003
  • Appl. No.:
    10/395810
  • Inventors:
    Brydon Bennett - San Diego CA, US
    Shripad Bhagwat - San Diego CA, US
    Anthony Manning - San Diego CA, US
    Brion Murray - San Diego CA, US
    Eoin O'Leary - San Diego CA, US
    Yoshitaka Satoh - San Diego CA, US
  • International Classification:
    C07D231/54
    A61K031/416
  • US Classification:
    514/406000, 548/358500
  • Abstract:
    This invention generally relates to methods for treating or preventing an inflammatory disease or disorder comprising administering to a patient in need thereof an effective amount of a Pyrazoloanthrone Derivative having the following structure: or a pharmaceutically acceptable salt thereof, wherein Rand Rare as defined herein.
  • Methods For Preserving Tissue

    view source
  • US Patent:
    20050266391, Dec 1, 2005
  • Filed:
    Jan 14, 2005
  • Appl. No.:
    11/035842
  • Inventors:
    Brydon Bennett - San Diego CA, US
    David Brenner - New York NY, US
    Jerome Zeldis - Princeton NJ, US
  • International Classification:
    A01N001/00
  • US Classification:
    435001100, 514406000
  • Abstract:
    The invention generally relates to methods for preserving tissue, preventing reperfusion injury to implanted tissue, preventing transplant rejection or preserving a cell to be transplanted, comprising contacting tissue or a cell with an effective amount of a JNK Inhibitor. The invention further relates to compositions useful for the preservation of tissue, the compositions comprising an effective amount of a JNK Inhibitor.
  • Methods For Treating, Preventing And Managing Chronic Lymphocytic Leukemia With Indazole Compounds

    view source
  • US Patent:
    20070060616, Mar 15, 2007
  • Filed:
    Aug 30, 2006
  • Appl. No.:
    11/512836
  • Inventors:
    Brydon Bennett - San Diego CA, US
    Shripad Bhagwat - San Diego CA, US
  • International Classification:
    A61K 31/454
  • US Classification:
    514322000
  • Abstract:
    This invention is generally directed to the use of Indazole Compounds for treating or preventing chronic lymphocytic leukemia. The methods comprise the treatment or prevention of chronic lymphocytic leukemia comprising administering an effective amount of an indazole compound, or a pharmaceutically acceptable salt or composition thereof, to a patient in need thereof.
  • Methods Of Treatment, Improvement And Prevention Using Haloaryl Substituted Aminopurines

    view source
  • US Patent:
    20120129807, May 24, 2012
  • Filed:
    Oct 20, 2011
  • Appl. No.:
    13/277282
  • Inventors:
    Brydon L. Bennett - San Diego CA, US
    Brian Edwin Cathers - San Diego CA, US
    Heather Raymon - San Diego CA, US
    Weilin Xie - San Diego CA, US
    Jaman May Maroni - Watchung NJ, US
  • International Classification:
    A61K 31/69
    A61K 31/5377
    A61P 17/00
    A61K 31/551
    A61P 17/06
    A61P 17/04
    A61P 1/04
    A61P 1/00
    A61P 1/10
    A61P 19/02
    A61P 17/14
    A61P 11/00
    A61P 17/02
    A61P 1/12
    A61K 31/52
  • US Classification:
    514 64, 5142634, 51426322, 51426323, 51426324, 5142632, 5142342, 51425216, 514218, 51425211
  • Abstract:
    Provided herein are Aminopurine Compounds having the following structure:wherein R, Rand Rare as defined herein, compositions comprising an effective amount of an Aminopurine Compound and methods for treating or preventing scleroderma, keloids, UV injury, or sunburn, and methods for improving or preventing scar formation.
  • Substituted Diaminocarboxamide And Diaminocarbonitrile Pyrimidines, Compositions Thereof, And Methods Of Treatment Therewith

    view source
  • US Patent:
    20130029987, Jan 31, 2013
  • Filed:
    Apr 20, 2012
  • Appl. No.:
    13/451574
  • Inventors:
    Brydon L. Bennett - San Diego CA, US
    Jan Elsner - San Diego CA, US
    Paul Erdman - San Diego CA, US
    Robert Hilgraf - San Diego CA, US
    Laurie Ann LeBrun - San Diego CA, US
    Meg McCarrick - San Diego CA, US
    Mehran F. Moghaddam - Carlsbad CA, US
    Mark A. Nagy - San Diego CA, US
    Stephen Norris - San Diego CA, US
    David A. Paisner - Portland OR, US
    Marianne Sloss - San Diego CA, US
    William J. Romanow - San Diego CA, US
    Yoshitaka Satoh - Poway CA, US
    Jayashree Tikhe - San Diego CA, US
    Won Hyung Yoon - San Diego CA, US
    Mercedes Delgado - San Diego CA, US
  • International Classification:
    A61K 31/505
    C07D 405/12
    C07D 401/12
    A61K 31/506
    C07D 405/14
    C12N 5/071
    C07D 413/12
    A61K 31/5377
    A61P 1/16
    A61P 3/10
    A61P 3/00
    C07D 239/48
    C07D 403/12
  • US Classification:
    5142358, 544323, 514275, 544324, 544296, 544122, 544230, 435375
  • Abstract:
    Provided herein are Diaminopyrimidine Compounds having the following structures:

Get Report for Brydon L Bennett from San Diego, CA, age ~53
Control profile